These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 4180004

  • 1. [Clinical experience with the vasoconstrictor action of H 1032 on the nasal mucosa].
    Carta F.
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1967; 78(4):510-9. PubMed ID: 4180004
    [No Abstract] [Full Text] [Related]

  • 2. [Experience in the use of a local vasoconstrictor, Otrivin--clinical observation by double blind, cross over method and the effect on the nasal mucosa].
    Sugiura S.
    Jibiinkoka; 1971 Jan; 43(1):71-86. PubMed ID: 4099381
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of the preparation "Betadrin-Polfa"].
    Klonowski S, Semczuk B, Pomykalski M, Czerwonka R.
    Pol Tyg Lek; 1969 Feb 11; 24(6):209-11. PubMed ID: 4180773
    [No Abstract] [Full Text] [Related]

  • 4. [Observations on the clinical experimentation of a new endonasal vasoconstrictor agent].
    Bigoni A.
    Minerva Otorinolaringol; 1967 Feb 11; 17(7):137-41. PubMed ID: 4181043
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Experimental study of L 5818 Labaz used as a vasocontrictor in nasal instillation].
    Melon J, Boniver R, Zicot-Houters L.
    Acta Otorhinolaryngol Belg; 1974 Feb 11; 28(3):355-64. PubMed ID: 4138436
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of nasal decongestants on locomotor activity of the ciliary apparatus of nasal mucosa in patients with acute purulent rhinosinusitis].
    Kramnoĭ AI, Kozlov VS.
    Vestn Otorinolaringol; 2010 Feb 11; (1):67-8. PubMed ID: 20436429
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological background to decongesting and anti-inflammatory treatment of rhinitis and sinusitis.
    Malm L.
    Acta Otolaryngol Suppl; 1994 Feb 11; 515():53-5; discussion 55-6. PubMed ID: 7520660
    [Abstract] [Full Text] [Related]

  • 18. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
    Rüggeberg F.
    Z Allgemeinmed; 1974 Apr 20; 50(11):535-7. PubMed ID: 4135074
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.